The cost-effectiveness of transcatheter aortic valve replacement for nonsurgical candidates : Revisionist history or the final word?

Circulation: Cardiovascular Quality and Outcomes

Volumn 6, Issue 4, 2013, Pages 376-378

  Reynolds, Matthew R ^a,b   Cohen, David J ^c  

^a HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^b LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aortic valve stenosis; Cost benefit analysis; Editorials

Indexed keywords

AORTA STENOSIS; CARDIOVASCULAR MORTALITY; CLINICAL TRIAL (TOPIC); COST EFFECTIVENESS ANALYSIS; DISEASE SIMULATION; EDITORIAL; FOLLOW UP; FUNCTIONAL STATUS; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INTENTION TO TREAT ANALYSIS; LIFE EXPECTANCY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; SURVIVAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSLUMINAL VALVULOPLASTY; UNITED STATES;

AORTIC VALVE STENOSIS; COST-BENEFIT ANALYSIS; EDITORIALS;

AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; HEALTH CARE COSTS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS;

EID: 84884493633     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.113.000330     Document Type: Editorial

References (15)

1. Cutler DM, Rosen AB, Vijan S. The value of medical spending in the United States, 1960-2000. N Engl J Med. 2006;355:920-927.
2. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.
3. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, Thourani VH, Babaliaros VC, Webb JG, Herrmann HC, Bavaria JE, Kodali S, Brown DL, Bowers B, Dewey TM, Svensson LG, Tuzcu M, Moses JW, Williams MR, Siegel RJ, Akin JJ, Anderson WN, Pocock S, Smith CR, Leon MB; PARTNER Trial Investigators. Transcatheter aorticvalve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1696-1704.
4. Reynolds MR, Magnuson EA, Lei Y, Leon MB, Smith CR, Svensson LG, Webb JG, Babaliaros VC, Bowers BS, Fearon WF, Herrmann HC, Kapadia S, Kodali S, Makkar RR, Pichard AD, Cohen DJ. Health related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation. 2011;124:1964-1972.
5. Simons CT, Cipriano LE, Shah RU, Garber AM, Owens DK, Hlatky MA. Transcatheter aortic valve replacement in non-surgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes. 2013;6:419-428.
6. Watt M, Mealing S, Eaton J, Piazza N, Moat N, Brasseur P, Palmer S, Busca R, Sculpher M. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart. 2012;98:370-376.
7. Reynolds MR, Magnuson EA, Wang K, Lei Y, Vilain K, Walczak J, Kodali SK, Lasala JM, O'Neill WW, Davidson CJ, Smith CR, Leon MB, Cohen DJ; PARTNER Investigators. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation. 2012;125:1102-1109.
8. Gada H, Kapadia SR, Tuzcu EM, Svensson LG, Marwick TH. Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Cardiol. 2012;109:1326-1333.
9. Doble B, Blackhouse G, Goeree R, Xie F. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective. J Thorac Cardiovasc Surg. 2013;146:52-60.e3.
10. Hancock-Howard RL, Feindel CM, Rodes-Cabau J, Webb JG, Thompson AK, Banz K. Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings. J Med Econ. 2013;16:566-574.
11. Neyt M, Van Brabandt H, Devriese S, Van De Sande S. A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open. 2012;2:e001032.
12. Ross J Jr, Braunwald E. Aortic stenosis. Circulation. 1968;38(1 Suppl):61-67.
13. Arias E. United States life tables, 2008. National Vital Stat Rep. 2012;61:11.
14. Hartman M, Catlin A, Lassman D, Cylus J, Heffler S. U.S. Health spending by age, selected years through 2004. Health Aff (Millwood). 2008;27:w1-w12.
15. Dewey TM. New data from PARTNER continued access (non-randomized): transapical outcomes after TAVR (abstract). Presented October 22, 2012 at Transcatheter Therapeutics, Miami, FL.